Interesting facts
Interesting Facts about 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-pyrazolidine-3,5-dione
4-butyl-1-(4-hydroxyphenyl)-2-phenyl-pyrazolidine-3,5-dione is a fascinating compound that belongs to the class of pyrazolidine derivatives. Here are some engaging insights about this intriguing compound:
- Pharmaceutical Relevance: Compounds like this one have been studied for their potential therapeutic applications, particularly as anti-inflammatory or analgesic agents. Their structure often influences their biological activity, making synthetic modifications an exciting area of research.
- Structure-Activity Relationship: The relationship between the chemical structure of pyrazolidine derivatives and their pharmacological effects is a key focus in medicinal chemistry. Understanding how variations (like the butyl group or phenolic modifications) affect these properties can lead to the development of more effective medications.
- Mechanism of Action: Some derivatives of this compound may work by inhibiting specific enzymes involved in the inflammatory process, such as cyclooxygenase (COX). Researching these pathways is crucial for designing better therapeutic agents with fewer side effects.
- Research and Development: Ongoing studies are concentrated on synthesizing new analogs, expanding the potential applications of this compound in various fields, including oncology and neurology. This highlights the compound's versatility in pharmacological contexts.
- Chemical Versatility: The presence of functional groups like the hydroxy group enhances its reactivity and potential interactions with biological targets, making it a subject of interest for further chemical exploration.
As researchers delve into the suitability of 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-pyrazolidine-3,5-dione for various applications, it becomes evident that the quest for understanding its properties and possibilities is as crucial as its synthesis.
Synonyms
oxyphenbutazone
129-20-4
Oxyphenylbutazone
Tandearil
Crovaril
Flogitolo
Flogoril
Visubutina
Frabel
Oxalid
Neo-Farmadol
Oxifenylbutazon
Oxiphenbutazone
Butapirone
Californit
Oxazolidin
Flamaril
Tanderil
Oxyphenobutazone
p-Oxyphenylbutazone
Oxi-Fenibutol
Etrozolidina
Idrobutazina
Oxyphentamin
Artroflog
Butaflogin
Butanova
Butazonic
Butilene
Deflogin
Flanaril
Floghene
Flogistin
Flogodin
Flogostop
Flopirina
Infammil
Ipabutona
Isobutazina
Isobutil
Offitril
Oxibutol
Pirabutina
Piraflogin
Poliflogil
Tandacote
Tandalgesic
Tendearil
Flogal
Infamil
Iridil
Mysite
Neofen
Optimal
Remazin
Reumox
Rumapax
Telidal
Valioil
Metabolite I
Oxazolidin-Geigy
Oxybuton
p-Hydroxyphenylbutazone
Oxiphenbutazonum
Flegmostam
Hydroxyphenylbutazon
Oxazolioin
Reunabutal
Aradinum
Butanora
Portoril
Telidac
Usaf Ge-14
Genal
Cinophen-N
Oxifenbutazona
Oxyphenbutazone anhydrous
Suganril
Oxyphenbutazonum
3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-
Ossifenbutazone
Tanderal
Reozon
Oxyphenbutazone [INN]
1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-butylpyrazolidine
BM 1
1-(p-Hydroxyphenyl)-2-phenyl-4-butyl-3,5-pyrazolidinedione
4-Butyl-1-(4-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione
4-Butyl-1-(p-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione
4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE-3,5-DIONE
4-Butyl-2-(p-hydroxyphenyl)-1-phenyl-3,5-pyrazolidinedione
Oxifenbutazona [INN-Spanish]
Oxyphenbutazonum [INN-Latin]
4-Butyl-2-(4-hydroxyphenyl)-1-phenyl-3,5-dioxopyrazolidine
CCRIS 6717
HSDB 3144
G 27202
1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-n-butylpyrazolidine
3,5-Dioxo-1-phenyl-2-(p-hydroxyphenyl)-4-N-butylpyrazolidene
EINECS 204-936-2
NSC 526053
NSC-526053
UNII-A7D84513GV
1-p-Hydroxyphenyl-2-phenyl-3,5-dioxo-4-N-butylpyrazolidine
BRN 0307474
3,5-Pyrazolidinedione, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl-
DTXSID1045291
CHEBI:76258
AI3-26792
A7D84513GV
3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl
MLS003373849
DTXCID9025291
RO-04-4410
G-27202
G-29701
Oxyphenbutazone (INN)
(+/-)-OXYPHENBUTAZONE ANHYDROUS
1-(p-Hydroxyphenyl)-2-phenyl-3,5-dioxo-4-N-butylpyrazolidine
OXYPHENBUTAZONE ANHYDROUS, (+/-)-
Ossifenbutazone [DCIT]
NSC-757261
AB00052064_08
Oxifenbutazona (INN-Spanish)
Oxyphenbutazonum (INN-Latin)
Hydroxyphenylbutazone
OXYPHENBUTAZONE (IARC)
Oxyphenyl butazone
OPB
SR-05000001689
(+/-)-OXYPHENBUTAZONE MONOHYDRATE
OXYPHENBUTAZONE MONOHYDRATE, (+/-)-
metabolitie
oxifenbutazone
Romaxin
NCGC00016389-01
CAS-129-20-4
Reozon (TN)
Oxyphenbutazone (TN)
Spectrum_001073
Oxyphenbutazone, Tanderil
Prestwick0_001049
Prestwick1_001049
Prestwick2_001049
Prestwick3_001049
Spectrum2_000153
Spectrum3_000535
Spectrum4_001155
Spectrum5_000998
CHEMBL1228
OXYPHENBUTAZONE [MI]
SCHEMBL25857
BSPBio_000978
BSPBio_002149
KBioGR_001729
KBioSS_001553
DivK1c_000302
OXYPHENBUTAZONE [HSDB]
SPECTRUM1500455
SPBio_000286
SPBio_002909
BPBio1_001076
OXYPHENBUTAZONE [WHO-DD]
HMS500P04
HY-B1355A
KBio1_000302
KBio2_001553
KBio2_004121
KBio2_006689
KBio3_001649
M01AA03
M02AA04
S01BC02
NINDS_000302
1-(p-hydroxyphenyl)-2-phenyl-4-butylpyrazolidine-3,5-dione
4-butyl-1-(4-hydroxyphenyl)-2-phenyl-pyrazolidine-3,5-dione
BDBM200298
GLXC-03195
HMS1571A20
HMS1920D20
HMS2091L20
HMS2098A20
HMS2236G07
HMS3373B01
HMS3715A20
Pharmakon1600-01500455
BCP20014
Tox21_110414
3,5-Pyrazolidinedione, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl- (VAN)
CCG-38944
EX-A11089
NSC526053
NSC757261
AKOS024362800
Tox21_110414_1
DB03585
FO67395
IDI1_000302
NCGC00094748-01
NCGC00094748-02
NCGC00094748-03
NCGC00094748-04
NCGC00094748-07
(+/-)-Oxyphenbutazone-d9(N-butyl-d9)
DA-63652
MS-24837
SBI-0051471.P003
3, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl-
AB00052064
CS-0013099
NS00009020
WLN: T5VNNV EHJ BR DQ & CR & E4
3, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-
OXYPHENBUTAZONE 4-HYDROXYPHENYLBUTAZONE
C19494
D08324
EN300-761427
F82061
Oxyphenbutazone 1000 microg/mL in Acetonitrile
Q4116192
SR-05000001689-1
SR-05000001689-3
BRD-A33749298-001-05-0
BRD-A33749298-001-18-3
3,5-Pyrazolidinedione, 4-butyl-1-(p-hydroxyphenyl)-2-phenyl-(VAN)
204-936-2
Solubility of 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-pyrazolidine-3,5-dione
The solubility of the compound C19H20N2O2, known as 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-pyrazolidine-3,5-dione, is influenced by several factors related to its molecular structure. Understanding the solubility characteristics is crucial for applications in pharmaceuticals, as this compound may exhibit different behavior in various solvents.
Key Points on Solubility:
Overall, while this compound exhibits certain polar characteristics due to the hydroxyl group, it is also likely to show limited solubility in highly polar solvents, making its solubility a complex interplay of hydrophilic and hydrophobic interactions. Future experimental studies would provide further insights into the exact solubility profiles of this intriguing chemical compound.